| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Haemophilus influenzae (NCTC 11931) |
- |
- |
8 － ? |
Clarithromycin (Biaxin)  |
401 |
| Haemophilus influenzae (NCTC 11931) |
- |
- |
8 － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
401 |
| Haemophilus influenzae (NCTC 11931) |
- |
- |
16 － ? |
Roxithromycin |
401 |
| Haemophilus influenzae (Neqas 4012) |
- |
- |
0.008 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
191 |
| Haemophilus influenzae (NN400) |
- |
- |
0.78 － ? |
FNQ13 |
257 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
≤0.004 |
≤0.004 |
≤0.004 － <=0.004 |
Sitafloxacin |
130 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
≤0.004 |
≤0.004 |
≤0.004 － <=0.004 |
Sitafloxacin |
443 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.004 |
0.008 |
≤0.004 － 0.008 |
DK-507k |
130 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.004 |
0.008 |
≤0.004 － 0.008 |
Gemifloxacin |
268 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.004 |
0.008 |
≤0.004 － 0.015 |
Garenoxacin (T-3811, BMS-284756) |
268 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.004 |
0.008 |
≤0.004 － 8 |
DK-507k |
443 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.008 |
0.008 |
≤0.004 － 0.008 |
Gatifloxacin (Tequin) |
443 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.008 |
0.008 |
≤0.004 － 0.008 |
Gatifloxacin (Tequin) |
130 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.008 |
0.008 |
≤0.004 － 0.015 |
Garenoxacin (T-3811, BMS-284756) |
130 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.008 |
0.008 |
≤0.004 － 0.015 |
Garenoxacin (T-3811, BMS-284756) |
443 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.008 |
0.008 |
≤0.004 － 0.08 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
268 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.008 |
0.015 |
≤0.004 － 0.015 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
130 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.008 |
0.015 |
≤0.004 － 0.015 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
443 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.008 |
0.015 |
≤0.004 － 0.015 |
DC-159a |
268 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.015 |
0.015 |
0.008 － 0.015 |
Levofloxacin (Levaquin, Quixin) |
443 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.015 |
0.015 |
0.008 － 0.03 |
Moxifloxacin (BAY 12-8039, Avelox) |
268 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.015 |
0.03 |
0.008 － 0.03 |
Moxifloxacin (BAY 12-8039, Avelox) |
130 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.015 |
0.03 |
0.008 － 0.03 |
Moxifloxacin (BAY 12-8039, Avelox) |
443 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.12 |
0.5 |
≤0.012 － 0.5 |
Chloramphenicol (Chloromycetin) |
267 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.12 |
1 |
≤0.015 － 1 |
Cefixime (Suprax) |
267 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
1 |
2 |
0.25 － 4 |
Cefdinir (Omnicef, Cefdiel) |
267 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
2 |
4 |
2 － 8 |
Ampicillin (Omnipen) |
130 |
| Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
2 |
4 |
2 － 8 |
Ampicillin (Omnipen) |
443 |